Eosinophilia during psoriasis treatment with TNF antagonists.

Malisiewicz, Bartosz; Murer, Carla; Pachlopnik Schmid, Jana; French, Lars E; Schmid-Grendelmeier, Peter; Navarini, Alexander A

Malisiewicz, Bartosz; Murer, Carla; Pachlopnik Schmid, Jana; French, Lars E; Schmid-Grendelmeier, Peter; Navarini, Alexander A.

Dermatology ; 223(4): 311-5, 2011.

Article in En | MEDLINE | ID: mdl-22301393

Subject(s)

Anthralin/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; Dermatologic Agents/therapeutic use; Eosinophilia/chemically induced; Psoriasis/drug therapy; Adalimumab; Drug Therapy, Combination; Eosinophil Cationic Protein/blood; Etanercept; Female; Humans; Immunoglobulin G/therapeutic use; Male; Middle Aged; Receptors, Tumor Necrosis Factor/therapeutic use; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Anthralin / Dermatologic Agents / Eosinophilia / Antibodies, Monoclonal, Humanized Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Dermatology Journal subject: DERMATOLOGIA Year: 2011 Type: Article

Fulltext

XML

PubMed Links

Search on Google